 |
|
|
|
|
|
|
|
|
|
May 2012: Meetings at which KAI staff will be making presentations.
more
February 2012, Publication in Clinical Trials National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods, Grinnon ST, et. al.
September 2011 – KAI working in partnership with FEFA Inc. is designing a web portal for FDA's Center for Drug Evaluation and Research's(CDER), Computational Science Center. This portal will allow real time statistical analysis of data submitted as part of regulatory submissions.
more
|
|
|
|
|
|
|
KAI White Paper - Risk Based Monitoring: Maximizing Efficiency While Maintaining Quality 
Generic Drugs: Why the Controversy? more
Henry Jackson Foundation for the Advancement of Military Medicine more
The National Institute on Aging Clinical Research Toolbox for Investigators more
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Since 1986, KAI Research Inc., a wholly owned for-profit subsidiary of Altarum Institute (a small business under 500 employees), has focused on providing innovative,
cost-effective, and practical support to the pharmaceutical, biotech
and academic institutions and the National Institutes of Health (NIH).
KAI focuses its client services on:
|
Our Vision: |
|
|
Knowledge
Accountability
Innovation ...
|
KAI provides outstanding services to the clinical research community using state
of the art tools and a collaborative, "can do" approach.
Our Mission:
KAI is committed to:
- Exceeding client expectations through cutting-edge technological tools
in clinical research
- Providing regulatory, scientific, medical, and information technology
expert services and
- Providing the most reliable, cost-effective service in our industry.
|
|
|
|
 |
